Artrya Limited (AYA.AX)
AUD 0.47
(2.17%)
AUD 0.47
(2.17%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -15.4 Million | -10.73 Million | -9.6 Million | -1.48 Million | -1.62 Million | -95.94 Thousand |
| Net Income | -14 Million | -11.13 Million | -17.15 Million | -4.07 Million | -1.35 Million | -145.67 Thousand |
| Depreciation & Amortization | 1.99 Million | 552 Thousand | 202 Thousand | 38.51 Thousand | 11.54 Thousand | 90.00 |
| Deferred income taxes | - | -1.08 Million | 804.39 Thousand | 1.05 Million | -353.12 Thousand | - |
| Stock-based compensation | 225 Thousand | 949 Thousand | 5.6 Million | 1.36 Million | 16.78 Thousand | - |
| Change in working capital | 694 Thousand | -170 Thousand | 1.41 Million | 1.26 Million | -297.97 Thousand | 49.64 Thousand |
| Other non-cash items | -4.32 Million | 1.09 Million | 5.12 Million | 233.19 Thousand | 370.41 Thousand | -43.9 Thousand |
| Investing Cash Flow | 2.7 Million | 15.82 Million | -26.58 Million | -1.85 Million | -15.48 Thousand | -3045.00 |
| Investments in PPE | -46 Thousand | -5.95 Million | -6.38 Million | -2.06 Million | -15.48 Thousand | -3045.00 |
| Acquisitions | - | 2000.00 | 3000.00 | 617.00 | - | - |
| Investment purchases | - | - | -20.27 Million | - | - | - |
| Sales/Maturities of investments | 125 Thousand | 20 Million | 4.49 Million | - | - | - |
| Other Investing Activities | 2.75 Million | 1.77 Million | -4.43 Million | 204.95 Thousand | - | - |
| Financing Cash Flow | -299 Thousand | -245 Thousand | 38.53 Million | 14.09 Million | 2.95 Million | 1 Million |
| Debt repayment | -311 Thousand | -265.00 | -107.00 | -31 Thousand | -10.48 Thousand | -9059.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -2.25 Million | - | - | - |
| Common Stock Issuance | 12 Thousand | 20 Thousand | 40.01 Million | 14.12 Million | 2.97 Million | 1 Million |
| Other Financing Activities | 12 Thousand | -264.73 Thousand | 778.21 Thousand | 14.12 Million | 2.96 Million | - |
| Accounts receivables | 623 Thousand | 430 Thousand | 690 Thousand | 294.27 Thousand | -398.65 Thousand | -1443.00 |
| Accounts payables | -192 Thousand | -408 Thousand | 524 Thousand | 838.3 Thousand | 68.63 Thousand | 45.52 Thousand |
| Inventory | - | - | - | - | 1.00 | - |
| Other working capital | 71 Thousand | -192 Thousand | 199 Thousand | 133.26 Thousand | 32.04 Thousand | 5558.00 |
| Cash at beginning of period | 20.13 Million | 15.55 Million | 12.98 Million | 2.22 Million | 910.07 Thousand | 2.00 |
| Cash at end of period | 7.13 Million | 20.28 Million | 15.28 Million | 12.98 Million | 2.22 Million | 910.07 Thousand |
| Capital Expenditure | -46 Thousand | -5.95 Million | -6.38 Million | -2.06 Million | -15.48 Thousand | -3045.00 |
| Effect of forex changes on cash | 3000.00 | 4000.00 | 5000.00 | -10.74 Million | -1.31 Million | - |
| Net cash flow / Change in cash | -12.99 Million | 4.72 Million | 2.3 Million | 10.75 Million | 1.31 Million | 910.07 Thousand |
| Free Cash Flow | -15.45 Million | -16.68 Million | -15.98 Million | -3.55 Million | -1.63 Million | -98.98 Thousand |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -14 Million | -3560.50 | -3560.50 | -6.87 Million | -3439.50 | -11.13 Million |
| Depreciation & Amortization | 1.99 Million | 503.00 | 503.00 | 989 Thousand | 494.50 | 552 Thousand |
| Deferred income taxes | - | - | - | - | - | -1.08 Million |
| Stock-based compensation | - | 77.50 | 77.50 | 35.00 | 35.00 | 949 Thousand |
| Change in working capital | 502 Thousand | 347.00 | 347.00 | - | - | -170 Thousand |
| Other non-cash items | 113 Thousand | -1437.00 | -1437.00 | 867 Thousand | -723.50 | 1.09 Million |
| Investing Cash Flow | 2.24 Million | 142.50 | 142.50 | 2.15 Million | 1210.00 | 15.82 Million |
| Investments in PPE | -46 Thousand | -16.00 | -16.00 | -14 Thousand | -7.00 | -5.95 Million |
| Acquisitions | - | - | - | - | - | 2000.00 |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | 125 Thousand | 125 Thousand | - | - | - | 20 Million |
| Other Investing Activities | 2.16 Million | 158.50 | 158.50 | 2.16 Million | 1217.00 | 1.77 Million |
| Financing Cash Flow | -299 Thousand | -87.00 | -87.00 | -125 Thousand | -62.50 | -245 Thousand |
| Debt repayment | - | - | - | - | - | -265.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 12 Thousand | 3000.00 | - | 9000.00 | - | 20 Thousand |
| Other Financing Activities | - | -87.00 | -87.00 | -62.50 | -62.50 | -264.73 Thousand |
| Accounts receivables | 623 Thousand | 311.50 | 311.50 | - | - | 430 Thousand |
| Accounts payables | -192 Thousand | - | - | - | - | -408 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 71 Thousand | 35.50 | 35.50 | - | - | -192 Thousand |
| Cash at beginning of period | 20.28 Million | 15.15 Million | - | 20.28 Million | - | 15.55 Million |
| Cash at end of period | 7.28 Million | 7.28 Million | -4009.50 | 15.15 Million | -2489.50 | 20.28 Million |
| Capital Expenditure | -46 Thousand | -16.00 | -16.00 | -14 Thousand | -7.00 | -5.95 Million |
| Effect of forex changes on cash | - | 5.00 | 5.00 | -3.50 | -3.50 | 4000.00 |
| Net cash flow / Change in cash | -12.99 Million | -7.87 Million | -4009.50 | -5.12 Million | -2489.50 | 4.72 Million |
| Free Cash Flow | -14.99 Million | -4086.00 | -4086.00 | -7.01 Million | -3640.50 | -16.68 Million |
NER
SPNS
BIOCQ
6H90
002181
HTCMF